Novel mechanism of androgen receptor regulation through switching by long non-coding RNA LINC01126

Leandro Blas; Masaki Shiota

doi:10.1002/ctd2.264

Clinical and Translational Discovery ›› 2024, Vol. 4 ›› Issue (1) :e264 DOI: 10.1002/ctd2.264

COMMENTARY

Novel mechanism of androgen receptor regulation through switching by long non-coding RNA LINC01126

Leandro Blas
, Masaki Shiota ^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Leandro Blas, Masaki Shiota. Novel mechanism of androgen receptor regulation through switching by long non-coding RNA LINC01126. Clinical and Translational Discovery, 2024, 4(1): e264 DOI:10.1002/ctd2.264

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	MaoY, YangG, LiY, LiangG, XuW, HuM. Advances in the current understanding of the mechanisms governing the acquisition of castration-resistant prostate cancer. Cancers. 2022;14:3744.

[2]	GhildiyalR, SawantM, RenganathanA, et al. Loss of long noncoding RNA NXTAR in prostate cancer augments androgen receptor expression and enzalutamide resistance. Cancer Res. 2022;82:155-168.

[3]	GaoK, LiX, NiJ, et al. Non-coding RNAs in enzalutamide resistance of castration-resistant prostate cancer. Cancer Lett. 2023;566:216247.

[4]	CaiY, ChenM, GongY, et al. Androgen-repressed lncRNA LINC01126 drives castration-resistant prostate cancer by regulating the switch between O-GlcNAcylation and phosphorylation of androgen receptor. Clin Transl Med. [in press].

[5]	ShiotaM, EndoS, BlasL, Fujimoto N, EtoM. Steroidogenesis in castration-resistant prostate cancer. Urol Oncol. 2023;41:240-251.

[6]	ShiotaM, Akamatsu S, TsukaharaS, NagakawaS, Matsumoto T, EtoM. Androgen receptor mutations for precision medicine in prostate cancer. Endocr Relat Cancer. 2022;29:R143-R155.

[7]	MorgentalerA, TraishAM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol. 2009;55:310-320.

[8]	ShiotaM, Takeuchi A, SongY, et al. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression. Endocr Relat Cancer. 2011;18:505-517.

[9]	LiM, DingX, ZhangY, et al. Antisense oligonucleotides targeting lncRNA AC104041.1 induces antitumor activity through Wnt2B/β-catenin pathway in head and neck squamous cell carcinomas. Cell Death Dis. 2020;11:672.

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.